The tissue distribution and function of Relaxin-3 and RXFP3 indicate potential therapeutic application of RXFP3 modulators to treat stress/anxiety, cognitive disorders and metabolic diseases [19]. The gene discussed is RXFP3; the disease is Cognitive impairment.